Why the study?
Does isoproterenol unmask retrograde conduction in concealed accessory pathways during electrophysiology studies?
Does isoproterenol unmask retrograde conduction in concealed accessory pathways during electrophysiology studies?
Isoproterenol can unmask total functional conduction block in concealed accessory pathways, highlighting the importance of adrenergic stimulation during EP studies for undiagnosed tachycardias.
Answers are grounded in this paper and cite their sources.
May support isoproterenol in select EP studies for concealed pathways; single case leaves open broader validation.
A 52-year-old female with no structural heart disease presented with a right bundle branch block (RBBB)/right axis deviation tachycardia with a cycle length of 300 msec. P waves were not discernible on the surface ECG. Baseline electrophysiology study in the drug-free state revealed no evidence for anterograde or retrograde conducting accessory pathways (APs) or for dual AV node physiology. Retrograde VA block with AV dissociation was present at a ventricular paced cycle length of 600 msec (sinus cycle length of 635-700 msec). AV nodal Wenckebach occurred during decremental atrial pacing at a cycle length of 300 msec. During isoproterenol administration, a left lateral AP with retrograde only conduction became manifest with 1:1 VA conduction to 380 msec. No anterograde AP conduction was present. Orthodromic reciprocating tachycardia with a cycle length of 285-315 msec was easily induced. We conclude that total functional conduction block can exist in APs, and unmasking of total conduction block can be accomplished with isoproterenol. All patients with undiagnosed tachycardias should have full repeat stimulation studies during adrenergic stimulation if the initial baseline evaluation is nondiagnostic.
No takes yet. Share an insight, caveat, or question.
Frazier et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: